Let us help keep your trials going when your current sites shut down.
AES and our centralized, global network of over 180 research locations on five continents are standing by to help with trial continuity. As your research sites are shutting down due to COVID-19, our open sites can accept transfer of your patients in under a week. We have the scale and coordinated resources to rapidly and compliantly accommodate thousands of randomized patients…patients who will otherwise be unable to continue trial participation when your sites close.
Please provide your contact information so that we can schedule a call to discuss this option, along with other trial continuity solutions such as virtual patient visits, virtual trial sites, remote site start ups, and more: